KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
NASDAQ:XLRN
Delisted

Acceleron Pharma Inc. Stock Price (Quote)

$178.75
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $178.75 $178.75 Friday, 27th May 2022 XLRN stock ended at $178.75. During the day the stock fluctuated 0% from a day low at $178.75 to a day high of $178.75.
90 days $178.75 $178.75
52 weeks $113.49 $189.99

Historical Acceleron Pharma Inc. prices

Date Open High Low Close Volume
Oct 29, 2019 $44.44 $44.56 $43.23 $43.65 260 158
Oct 28, 2019 $42.51 $44.53 $42.06 $44.40 188 947
Oct 25, 2019 $41.95 $42.59 $41.52 $42.29 160 397
Oct 24, 2019 $42.70 $42.79 $41.71 $41.95 154 928
Oct 23, 2019 $42.91 $43.46 $42.50 $42.50 118 593
Oct 22, 2019 $42.76 $43.53 $42.74 $42.89 125 038
Oct 21, 2019 $42.59 $43.14 $42.36 $42.53 211 065
Oct 18, 2019 $43.01 $43.37 $41.99 $42.15 203 789
Oct 17, 2019 $41.93 $43.42 $41.90 $43.25 181 289
Oct 16, 2019 $41.81 $42.40 $41.60 $41.61 487 366
Oct 15, 2019 $40.41 $42.29 $40.24 $41.92 236 376
Oct 14, 2019 $39.27 $41.17 $39.27 $40.26 451 743
Oct 11, 2019 $38.75 $39.95 $38.75 $39.47 233 500
Oct 10, 2019 $38.90 $39.20 $38.15 $38.37 207 419
Oct 09, 2019 $40.67 $40.83 $38.40 $38.67 331 750
Oct 08, 2019 $40.80 $41.07 $40.07 $40.44 269 264
Oct 07, 2019 $40.17 $41.70 $40.02 $41.35 493 834
Oct 04, 2019 $39.73 $40.70 $38.82 $40.41 510 873
Oct 03, 2019 $39.31 $40.26 $38.33 $39.50 219 004
Oct 02, 2019 $38.34 $39.36 $37.60 $39.18 267 550
Oct 01, 2019 $39.61 $40.41 $38.54 $38.57 175 126
Sep 30, 2019 $40.56 $40.94 $39.25 $39.51 279 182
Sep 27, 2019 $41.18 $42.02 $40.18 $40.43 194 980
Sep 26, 2019 $41.93 $42.73 $40.56 $40.97 315 920
Sep 25, 2019 $42.09 $42.68 $41.52 $41.98 233 238
Click to get the best stock tips daily for free!

About Acceleron Pharma Inc.

Acceleron Pharma. Acceleron Pharma Inc., a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of protein therapeutics for cancer and rare diseases. It is developing sotatercept to treat patients with chronic kidney disease, including mineral-bone disorder, vascular calcification, and anemia; and luspatercept to treat anemia and associated complications in patients with myelodysplastic syndromes and beta-thalassem... XLRN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT